BDTX
Black Diamond Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.12
+0.95%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-44.3%
Return on equity
-34.0%
Return on assets
-45.9%
Return on invested capital
0.00x
Asset turnover
-$32.0M
Cash from operations
$1.92
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026